Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid-19 lockdown.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
06 2021
Historique:
revised: 25 03 2021
received: 22 01 2021
accepted: 18 04 2021
pubmed: 29 4 2021
medline: 22 6 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

During the COVID-19 pandemic in-person visits for patients with cardiac implantable electronic devices should be replaced by remote monitoring (RM), in order to prevent viral transmission. A direct home-delivery service of the RM communicator has been implemented at 49 Italian arrhythmia centers. According to individual patient preference or the organizational decision of the center, patients were assigned to the home-delivery group or the standard in-clinic delivery group. In the former case, patients received telephone training on the activation process and use of the communicator. In June 2020, the centers were asked to reply to an ad hoc questionnaire to describe and evaluate their experience in the previous 3 months. RM was activated in 1324 patients: 821 (62%) received the communicator at home and the communicator was activated remotely. Activation required one additional call in 49% of cases, and the median time needed to complete the activation process was 15 min [25th-75th percentile: 10-20]. 753 (92%) patients were able to complete the correct activation of the system. At the time when the questionnaire was completed, 743 (90%) communicators were regularly transmitting data. The service was generally deemed useful (96% of respondents) in facilitating the activation of RM during the COVID-19 pandemic and possibly beyond. Home delivery of the communicator proved to be a successful approach to system activation, and received positive feedback from clinicians. The increased use of a RM protocol will reduce risks for both providers and patients, while maintaining high-quality care.

Sections du résumé

BACKGROUND
During the COVID-19 pandemic in-person visits for patients with cardiac implantable electronic devices should be replaced by remote monitoring (RM), in order to prevent viral transmission. A direct home-delivery service of the RM communicator has been implemented at 49 Italian arrhythmia centers.
METHODS
According to individual patient preference or the organizational decision of the center, patients were assigned to the home-delivery group or the standard in-clinic delivery group. In the former case, patients received telephone training on the activation process and use of the communicator. In June 2020, the centers were asked to reply to an ad hoc questionnaire to describe and evaluate their experience in the previous 3 months.
RESULTS
RM was activated in 1324 patients: 821 (62%) received the communicator at home and the communicator was activated remotely. Activation required one additional call in 49% of cases, and the median time needed to complete the activation process was 15 min [25th-75th percentile: 10-20]. 753 (92%) patients were able to complete the correct activation of the system. At the time when the questionnaire was completed, 743 (90%) communicators were regularly transmitting data. The service was generally deemed useful (96% of respondents) in facilitating the activation of RM during the COVID-19 pandemic and possibly beyond.
CONCLUSIONS
Home delivery of the communicator proved to be a successful approach to system activation, and received positive feedback from clinicians. The increased use of a RM protocol will reduce risks for both providers and patients, while maintaining high-quality care.

Identifiants

pubmed: 33908052
doi: 10.1111/pace.14251
pmc: PMC8207054
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

995-1003

Informations de copyright

© 2021 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.

Références

JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Europace. 2010 May;12(5):674-9
pubmed: 20200019
BMJ. 2020 May 20;369:m1997
pubmed: 32434891
Eur Heart J. 2015 Jan 14;36(3):158-69
pubmed: 25179766
J Am Coll Cardiol. 2020 Sep 15;76(11):1363-1374
pubmed: 32534936
Heart Rhythm. 2020 Sep;17(9):e233-e241
pubmed: 32247013
Heart Rhythm. 2015 Jul;12(7):e69-100
pubmed: 25981148
Acta Cardiol. 2021 Apr;76(2):158-161
pubmed: 33203312
Intern Emerg Med. 2020 Nov;15(8):1445-1456
pubmed: 32889687
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1173-80
pubmed: 26092577
ESC Heart Fail. 2020 Oct 23;:
pubmed: 33094929
Arch Cardiovasc Dis. 2014 Oct;107(10):508-18
pubmed: 25218008
Circulation. 2013 Nov 26;128(22):2372-83
pubmed: 24043302
Cardiol Rev. 2015 May-Jun;23(3):135-41
pubmed: 25133468
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Cardiol. 2019 Jan;42(1):76-83
pubmed: 30421438
Europace. 2013 Nov;15(11):1601-8
pubmed: 23599169
J Interv Card Electrophysiol. 2019 Dec;56(3):327-333
pubmed: 31646429
J Cardiovasc Electrophysiol. 2019 Jul;30(7):1066-1077
pubmed: 30938894
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Heart. 2012 Mar;98(5):402-7
pubmed: 22115985
Int J Cardiol. 2021 Apr 1;328:247-249
pubmed: 33278416
Heart Rhythm. 2017 Jan;14(1):58
pubmed: 27670630
Pacing Clin Electrophysiol. 2020 Nov;43(11):1366-1372
pubmed: 33021739
Interact J Med Res. 2013 Sep 20;2(2):e27
pubmed: 24055720
Europace. 2020 Jul 1;22(7):1071-1082
pubmed: 32424395
J Cardiovasc Electrophysiol. 2014 Nov;25(11):1216-23
pubmed: 24964380
Pacing Clin Electrophysiol. 2021 Jun;44(6):995-1003
pubmed: 33908052
Lancet. 2020 Mar 28;395(10229):1015-1018
pubmed: 32197103
J Interv Card Electrophysiol. 2020 Oct 1;:
pubmed: 33006086
J Thromb Thrombolysis. 2021 Apr;51(3):571-576
pubmed: 33156441
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Circulation. 2010 Jul 27;122(4):325-32
pubmed: 20625110
Pacing Clin Electrophysiol. 2011 Aug;34(8):968-74
pubmed: 21477028
J Cardiovasc Electrophysiol. 2020 Nov;31(11):2814-2823
pubmed: 32954600

Auteurs

Michele Magnocavallo (M)

Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Alessia Bernardini (A)

Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Marco Valerio Mariani (MV)

Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Agostino Piro (A)

Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Massimiliano Marini (M)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Antonino Nicosia (A)

Cardiology Unit, Giovanni Paolo II Hospital, Ragusa, Italy.

Carmen Adduci (C)

Division of Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, St. Andrea Hospital, Rome, Italy.

Antonio Rapacciuolo (A)

Cardiology Unit, Università degli Studi di Napoli Federico II, Naples, Italy.

Davide Saporito (D)

Division of Cardiology, Infermi Hospital, Rimini, Italy.

Stefano Grossi (S)

Cardiology Department, Azienda Ospedaliera Ordine Mauriziano, Turin, Italy.

Giuseppe Santarpia (G)

Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.

Paola Vaccaro (P)

Cardiology Unit, Riuniti Hospital, P.O. Cervello, Palermo, Italy.

Roberto Rordorf (R)

Department of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.

Francesco Pentimalli (F)

Cardiology Unit, San Paolo Hospital, Savona, Italy.

Giuseppe Giunta (G)

Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Monica Campari (M)

Boston Scientific, Milan, Italy.

Sergio Valsecchi (S)

Boston Scientific, Milan, Italy.

Carlo Lavalle (C)

Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH